Neurogene Inc. (NGNE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 925K | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | -100% | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 854K | 787K | 0 | 0 | 0 | 15.35M | 0 | 817K | 825K | 12.18M | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | 88.32% | - | - | - | - |
| Gross Profit | -854K | -787K | 0 | 0 | 0 | -15.35M | 0 | 108K | -825K | -12.18M | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | 11.68% | - | - | - | - |
| Gross Profit Growth % | - | 94.87% | - | -100% | 100% | -25.96% | - | - | -0.86% | -1794.87% | 100% | 100% |
| Operating Expenses | 32.49M | 26.74M | 23.8M | 26.08M | 25.92M | 6.17M | 22.18M | 20.24M | 17.95M | 2.55M | 15.22M | 12.6M |
| OpEx % of Revenue | - | - | - | - | - | - | - | 2188.32% | - | - | - | - |
| Selling, General & Admin | 8.2M | 6.1M | 6.56M | 6.71M | 8.16M | 6.17M | 5.89M | 5.32M | 4.41M | 2.55M | 3.61M | 2.27M |
| SG&A % of Revenue | - | - | - | - | - | - | - | 574.59% | - | - | - | - |
| Research & Development | 25.15M | 20.64M | 17.24M | 19.37M | 17.76M | 15.35M | 16.29M | 15.74M | 13.54M | 12.18M | 11.61M | 10.32M |
| R&D % of Revenue | - | - | - | - | - | - | - | 1702.05% | - | - | - | - |
| Other Operating Expenses | -854K | 0 | 0 | 0 | 0 | -1000K | 0 | -817K | 0 | -1000K | 0 | 0 |
| Operating Income | -33.35M | -27.53M | -23.8M | -26.08M | -25.92M | -21.51M | -22.18M | -20.13M | -18.78M | -14.73M | -15.22M | -12.6M |
| Operating Margin % | - | - | - | - | - | - | - | -2176.65% | - | - | - | - |
| Operating Income Growth % | -28.67% | -27.97% | -7.29% | -29.54% | -38.02% | -46.01% | -45.74% | -59.84% | -44.07% | -3.38% | -17.07% | 20.64% |
| EBITDA | -32.49M | -26.74M | -23.02M | -25.31M | -25.16M | -20.71M | -21.37M | -19.32M | -17.95M | -13.9M | -14.39M | -11.77M |
| EBITDA Margin % | - | - | - | - | - | - | - | -2088.32% | - | - | - | - |
| EBITDA Growth % | -29.17% | -29.1% | -7.72% | -31.05% | -40.12% | -48.97% | -48.52% | -64.08% | -46.96% | -2.18% | -17.88% | 22.31% |
| D&A (Non-Cash Add-back) | 854K | 787K | 776K | 767K | 762K | 798K | 807K | 817K | 825K | 828K | 828K | 823K |
| EBIT | -33.35M | -27.53M | -20.95M | -22.02M | -22.64M | -21.51M | -20.21M | -18.49M | -16.92M | -14.73M | -14.57M | -11.86M |
| Net Interest Income | 2.26M | 2.67M | 2.74M | 2.93M | 3.2M | 2.27M | 1.84M | 2.03M | 2.32M | 778K | 646K | 740K |
| Interest Income | 2.26M | 2.67M | 2.74M | 2.93M | 3.21M | 2.27M | 1.84M | 2.04M | 2.32M | 781K | 650K | 743K |
| Interest Expense | 0 | 1K | 1K | 1K | 2K | 2K | 3K | 4K | 3K | 3K | 4K | 3K |
| Other Income/Expense | 2.42M | 2.79M | 2.85M | 4.07M | 3.27M | 2M | 1.96M | 1.64M | 1.86M | 17.12M | 642K | 736K |
| Pretax Income | -30.93M | -24.73M | -20.95M | -22.02M | -22.65M | -19.51M | -20.22M | -18.49M | -16.92M | 2.38M | -14.58M | -11.86M |
| Pretax Margin % | - | - | - | - | - | - | - | -1999.14% | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -30.93M | -24.73M | -20.95M | -22.02M | -22.65M | -19.51M | -20.22M | -18.49M | -16.92M | 2.38M | -14.58M | -11.86M |
| Net Margin % | - | - | - | - | - | - | - | -1999.14% | - | - | - | - |
| Net Income Growth % | -36.59% | -26.76% | -3.64% | -19.06% | -33.84% | -918.88% | -38.69% | -55.92% | -37.98% | 117.72% | -16.17% | 24.4% |
| Net Income (Continuing) | -30.93M | -24.73M | -20.95M | -22.02M | -22.65M | -19.51M | -20.22M | -18.49M | -16.92M | 2.38M | -14.58M | -11.86M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.39 | -1.60 | -0.99 | -1.05 | -1.08 | -1.31 | -1.19 | -1.09 | -1.00 | -1.21 | -0.41 | -0.21 |
| EPS Growth % | -28.7% | -22.14% | 16.81% | 3.67% | -8% | -8.26% | -190.24% | -419.05% | -284.62% | -278.13% | 82.63% | 25% |
| EPS (Basic) | -1.39 | -1.60 | -0.99 | -1.05 | -1.08 | -1.31 | -1.19 | -1.09 | -1.00 | -1.21 | -0.41 | -0.21 |
| Diluted Shares Outstanding | 22.31M | 15.49M | 21.17M | 21.06M | 21M | 14.85M | 16.95M | 16.94M | 16.9M | 12.82M | 11.1M | 56.16M |
| Basic Shares Outstanding | 22.31M | 15.49M | 21.17M | 21.06M | 21M | 14.85M | 16.95M | 16.94M | 16.9M | 12.82M | 11.1M | 56.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |